The position statement from cancer and bone societies updates recommendations from 2017 for managing bone loss and fracture ...

Romosozumab shows bone mineral density gain in postmenopausal women with severe osteoporosis, irrespective of prior exposure ...

Some of the most commonly used medications for osteoporosis can lead to osteonecrosis of the jaw (ONJ), a rare but serious ...

Fracture risk and treatment need careful individual assessment Osteopenia is the most common result of a bone mineral density (BMD) measurement by dual-energy x-ray absorptiometry (DXA) in older ...

Every sunshine comes with its fair share of rain.Vitamin D, which has long been celebrated as the “sunshine vitamin” — vital ...

These include the RANKL inhibitor denosumab (Prolia), the anabolic agents teriparatide (Forteo) and abaloparatide (Tymlos), ...

Rajesh K. Jain, MD, shares how race and ethnicity impact osteoporosis epidemiology and treatment in the United States.

This article was reviewed by Julia Switzer, MD, FACOG. Key takeaways: Women are more likely to have osteoporosis than men, ...

Menopause brings hormonal shifts and bone loss. This can lead to osteoporosis, a silent disease. Fractures become a risk. Early detection and lifestyl ...

Entera Bio’s osteoporosis candidate for postmenopausal women showed statistically significant improvements in bone density in ...